We are live on ! Find out more
DADC

D.A. Davidson & Co Portfolio holdings

AUM $18.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+2.55%
1 Year Est. Return
+24.63%
3 Year Est. Return
+70.71%
5 Year Est. Return
+77.77%
10 Year Est. Return
+255.18%
AUM
$4.43B
AUM Growth
+$304M
Cap. Flow
+$215M
Cap. Flow %
4.85%
Top 10 Hldgs %
28.31%
Holding
2,533
New
165
Increased
888
Reduced
729
Closed
137

Top Sells

Rank Stock Value
1
KRC icon
Kilroy Realty
KRC
+$14.6M
2
ABBV icon
AbbVie
ABBV
+$7.15M
3
CAG icon
Conagra Brands
CAG
+$6.73M
4
KBR icon
KBR
KBR
+$4.75M
5
DE icon
Deere & Co
DE
+$4.43M

Sector Composition

Rank Sector Weight
1 Healthcare 9.11%
2 Technology 8.74%
3 Industrials 8.05%
4 Financials 7.99%
5 Consumer Discretionary 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FEM icon
851
First Trust Emerging Markets AlphaDEX Fund
FEM
$745M
$259K 0.01%
11,104
+2,329
+27% +$53.3K
VDE icon
852
Vanguard Energy ETF
VDE
$10.1B
$259K 0.01%
2,936
+230
+8% +$21.2K
LKQ icon
853
LKQ Corp
LKQ
$6.58B
$258K 0.01%
7,847
-144
-2% -$4.45K
IBDC
854
DELISTED
iShares iBonds Mar 2020 Term Corporate ETF
IBDC
$258K 0.01%
9,854
-5,866
-37% -$154K
SNY icon
855
Sanofi
SNY
$104B
$256K 0.01%
5,359
-1,102
-17% -$52.7K
FUL icon
856
H.B. Fuller
FUL
$3B
$255K 0.01%
5,000
RYAM icon
857
Rayonier Advanced Materials
RYAM
$565M
$255K 0.01%
16,261
-750
-4% -$10.7K
NFX
858
DELISTED
Newfield Exploration
NFX
$254K 0.01%
8,932
+2,101
+31% +$69.2K
IYW icon
859
iShares US Technology ETF
IYW
$23.7B
$253K 0.01%
7,252
+260
+4% +$9.12K
CSRA
860
DELISTED
CSRA Inc.
CSRA
$253K 0.01%
7,985
+2,411
+43% +$72.2K
FBT icon
861
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.8B
$252K 0.01%
2,211
+1,506
+214% +$162K
FTV icon
862
Fortive
FTV
$19B
$252K 0.01%
6,321
-1,205
-16% -$47.4K
APU
863
DELISTED
AmeriGas Partners, L.P.
APU
$252K 0.01%
5,580
+1,027
+23% +$46.1K
ARMK icon
864
Aramark
ARMK
$15B
$251K 0.01%
+8,498
New +$233K
STOR
865
DELISTED
STORE Capital Corporation
STOR
$251K 0.01%
+11,215
New +$248K
TSLF
866
DELISTED
THL CREDIT SENIOR LOAN FUND
TSLF
$251K 0.01%
14,196
+1,051
+8% +$19.1K
ADI icon
867
Analog Devices
ADI
$181B
$250K 0.01%
3,219
+1,698
+112% +$135K
CUBE icon
868
CubeSmart
CUBE
$9.53B
$250K 0.01%
10,401
+164
+2% +$4.16K
IBB icon
869
iShares Biotechnology ETF
IBB
$9.31B
$249K 0.01%
2,418
-954
-28% -$94K
JBHT icon
870
JB Hunt Transport Services
JBHT
$27.1B
$249K 0.01%
2,733
+12
+0.4% +$1.06K
IVOO icon
871
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.73B
$248K 0.01%
4,238
+1,080
+34% +$63K
PRAH
872
DELISTED
PRA Health Sciences, Inc.
PRAH
$247K 0.01%
3,295
-71
-2% -$4.92K
SRCLP
873
DELISTED
Stericycle, Inc
SRCLP
$247K 0.01%
3,700
+1,400
+61% +$98.8K
FIVN icon
874
FIVE9
FIVN
$1.77B
$246K 0.01%
11,476
+1,976
+21% +$40.5K
LECO icon
875
Lincoln Electric
LECO
$13.8B
$245K 0.01%
2,667
-350
-12% -$31.5K

Similar funds

D.A. Davidson & Co's Q2 2017 Portfolio in Review

As of Q2 2017, D.A. Davidson & Co held 2,533 positions worth $4.43B, up 7.4% from $4.12B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

D.A. Davidson & Co deployed $215M of net new capital in Q2 2017, opening 165 new positions and adding to 888 existing holdings. Its largest new stake was AutoZone: 2,429 shares worth $1.39M.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, up from 9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was AbbVie, an estimated $7.15M trimmed.

  • D.A. Davidson & Co's largest Q2 2017 buy was AutoZone: 2,429 shares worth $1.39M.
  • D.A. Davidson & Co added most to Vanguard Value ETF in Q2 2017, an estimated $20.9M increase.
  • D.A. Davidson & Co's biggest Q2 2017 reduction was AbbVie, cutting an estimated $7.15M.
  • D.A. Davidson & Co fully exited Kilroy Realty in Q2 2017, selling an estimated $14.6M.
  • D.A. Davidson & Co's ten largest holdings make up 28% of its $4.43B portfolio in Q2 2017.
  • D.A. Davidson & Co opened 165 new positions and closed 137 in Q2 2017.
  • D.A. Davidson & Co's portfolio value rose 7.4% quarter-over-quarter to $4.43B.

Based on D.A. Davidson & Co's 13F filing for Q2 2017, filed 11 Aug 2017.